Recce Pharmaceuticals accelerates R327 trial for UTI patients with faster infusion rate approval Posted on October 24, 2023September 25, 2024 by recce_com Recce Pharmaceuticals accelerates R327 trial for UTI patients with faster infusion rate approval
Busiest quarter for Recce Pharmaceuticals: Cashed up for next phases of drug development Posted on October 23, 2023September 25, 2024 by recce_com Busiest quarter for Recce Pharmaceuticals: Cashed up for next phases of drug development
Recce Pharma says commercial potential of its anti-infectives is gaining recognition Posted on October 11, 2023September 25, 2024 by recce_com Recce Pharma says commercial potential of its anti-infectives is gaining recognition
Recce Pharmaceuticals raise to progress advanced anti-infective Posted on October 9, 2023September 25, 2024 by recce_com Recce Pharmaceuticals raise to progress advanced anti-infective
Global fund takes stake in Recce as synthetic antibiotic developer raises $11m Posted on October 6, 2023September 25, 2024 by recce_com Global fund takes stake in Recce as synthetic antibiotic developer raises $11m
Recce Pharmaceuticals raises further funds to progress trials from entitlement shortfall Posted on October 6, 2023September 25, 2024 by recce_com Recce Pharmaceuticals raises further funds to progress trials from entitlement shortfall
Recce Pharmaceuticals advances anti-infective development and clinical trials in FY23 Posted on October 2, 2023September 25, 2024 by recce_com Recce Pharmaceuticals advances anti-infective development and clinical trials in FY23
Recce Pharmaceuticals (ASX:RCE) completes cohort dosing in UTI rapid infusion trial Posted on September 22, 2023September 25, 2024 by recce_com Recce Pharmaceuticals (ASX:RCE) completes cohort dosing in UTI rapid infusion trial
Recce Pharmaceuticals (ASX:RCE) paves its way to commercialisation with breakthrough antibiotic, R327 Posted on September 20, 2023September 25, 2024 by recce_com Recce Pharmaceuticals (ASX:RCE) paves its way to commercialisation with breakthrough antibiotic, R327
Recce Pharmaceuticals (ASX:RCE) receives green light for higher dose in rapid infusion phase I/II UTI trial Posted on August 28, 2023September 25, 2024 by officialtpss Recce Pharmaceuticals (ASX:RCE) receives green light for higher dose in rapid infusion phase I/II UTI trial
